Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: Two case reports

It is well known that calcium channel blockers (CCBs) are the first line of therapy for vasospastic angina (VSA). Here, we report two cases of VSA with an increase in the frequency of angina attacks after switching from a brand-name to a generic CCB. In both cases, angina recurred upon switching fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto-Semba, Remi, Fujii, Yuichi, Ueda, Tomohiro, Oshita, Chikage, Teragawa, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867450/
https://www.ncbi.nlm.nih.gov/pubmed/29588810
http://dx.doi.org/10.4330/wjc.v10.i3.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867450/
https://www.ncbi.nlm.nih.gov/pubmed/29588810
http://dx.doi.org/10.4330/wjc.v10.i3.15

Ejemplares similares